{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:32:29Z","timestamp":1773707549880,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T00:00:00Z","timestamp":1674864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T00:00:00Z","timestamp":1674864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018957","name":"Cara","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To investigate additional potential clinical risk factors for preeclampsia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a nested case\u2013control study of preeclampsia and unaffected pregnancies. Cases were either from a prenatal screening database or from a national network of clinicians, and controls were from the same prenatal source. Preeclampsia was defined by international criteria which were endorsed by the Ukraine Ministry of Health. Questionnaires were used to record a range of pregnancy related factors, personal history of health conditions and family history, followed by a telephone interview to collect more details.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were 103 cases, 56 from the prenatal database and 47 from the clinicians, and 480 controls from the database. The two types of case did not differ in terms of age, weight, BMI or parity. Known risk factors were more common in cases than controls. In addition there was a 17-fold higher prevalence of cholelithiasis in cases compared with controls (29.1% versus 1.7%), a highly statistically significant difference (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001). There was also an 8.8-fold increase among the mothers of cases and controls (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001), and if either the patient or her mother had the disease the increase was 6.4-fold (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001). Including the father or sibling did not increase the relative risk.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Cholelithiasis is a clinical risk factor for preeclampsia which has not previously been reported. If confirmed by additional studies it may have utility in routine prenatal screening and provide insight into the pathogenesis of preeclampsia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00404-023-06936-7","type":"journal-article","created":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T11:41:58Z","timestamp":1674906118000},"page":"1497-1503","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cholelithiasis is an additional pre-pregnancy clinical risk factor for preeclampsia"],"prefix":"10.1007","volume":"308","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5846-1067","authenticated-orcid":false,"given":"Svitlana","family":"Arbuzova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaryta","family":"Nikolenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Cuckle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,28]]},"reference":[{"issue":"1","key":"6936_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ajog.2019.11.1247","volume":"223","author":"D Wright","year":"2020","unstructured":"Wright D, Wright A, Nicolaides KH (2020) The competing risk approach for prediction of preeclampsia. Am J Obstet Gynecol 223(1):12-23.e7. https:\/\/doi.org\/10.1016\/j.ajog.2019.11.1247","journal-title":"Am J Obstet Gynecol"},{"key":"6936_CR2","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1097\/AOG.0000000000001049","volume":"126","author":"ACOG. Committee Opinion No. 638","year":"2015","unstructured":"ACOG. Committee Opinion No. 638 (2015) First-trimester risk assessment for early-onset preeclampsia. Obstet Gynecol 126:e25-27. https:\/\/doi.org\/10.1097\/AOG.0000000000001049","journal-title":"Obstet Gynecol"},{"key":"6936_CR3","unstructured":"National Collaborating Centre for Women\u2019s and Children\u2019s Health (UK). Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy. London: RCOG Press, 2010. Bookshelf ID:\u00a0NBK62652"},{"issue":"6","key":"6936_CR4","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/uog.19039","volume":"51","author":"MY Tan","year":"2018","unstructured":"Tan MY, Wright D, Syngelaki A, Akolekar R, Cicero S, Janga D, Singh M, Greco E, Wright A, Maclagan K, Poon LC, Nicolaides KH (2018) Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE. Ultrasound Obstet Gynecol 51(6):743\u2013750. https:\/\/doi.org\/10.1002\/uog.19039","journal-title":"Ultrasound Obstet Gynecol"},{"key":"6936_CR5","doi-asserted-by":"publisher","unstructured":"Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM (2001) The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the international society for the study of hypertension in pregnancy (ISSHP). Hypertens Pregnancy 20: IX\u2013XIV. https:\/\/doi.org\/10.1081\/PRG-100104165","DOI":"10.1081\/PRG-100104165"},{"key":"6936_CR6","unstructured":"Unified clinical protocol of primary, secondary (specialized) and tertiary (highly specialized) medical care \"Hypertensive disorders during pregnancy, childbirth and the postpartum period. The Order of the Ministry of Health of Ukraine N 676, 31.12.2004, updated version N 151 dated on Jan 24, 2022."},{"key":"6936_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/10641950601148000","volume":"26","author":"S Thangaratinam","year":"2007","unstructured":"Thangaratinam S, Ismail K, Sharp S, Coomarasamy A, O\u2019Mahony F, Khan KS, O\u2019Brien S (2007) Prioritisation of tests for the prediction of preeclampsia complications: a Delphi survey. Hypertens Pregnancy 26:131\u2013138. https:\/\/doi.org\/10.1080\/10641950601148000","journal-title":"Hypertens Pregnancy"},{"key":"6936_CR8","doi-asserted-by":"publisher","unstructured":"Antoni\u0107 TD, Ardali\u0107 DC, Vladimirov SS, Banjac GS, Cabunac PJ, Zeljkovi\u0107 AR, Karad\u017eov-Orli\u0107 NT, Spasojevi\u0107-Kalimanovska VV, Mikovi\u0107 ZD, Stefanovi\u0107 AZ (2021) Cholesterol homeostasis is dysregulated in women with preeclampsia. Pol Arch Intern Med 131(12):16144. https:\/\/doi.org\/10.20452\/pamw.16144","DOI":"10.20452\/pamw.16144"},{"key":"6936_CR9","doi-asserted-by":"publisher","unstructured":"Chen Y, Ou W, Lin D, Lin M, Huang X, Shuhua Ni, Chen S, Yong J, O'Gara MC, Tan X, Liu R (2021) Increased Uric Acid, Gamma-Glutamyl Transpeptidase and Alkaline Phosphatase in Early-Pregnancy Associated with the Development of Gestational Hypertension and Preeclampsia. Front Cardiovasc Med 8: 756140. https:\/\/doi.org\/10.3389\/fcvm.2021.756140","DOI":"10.3389\/fcvm.2021.756140"},{"issue":"1","key":"6936_CR10","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1186\/s12884-022-04827-4","volume":"22","author":"S Nachshon","year":"2022","unstructured":"Nachshon S, Hadar E, Bardin R, Barbash-Hazan S, Borovich A, Braun M, Shmueli A (2022) The association between chronic liver diseases and preeclampsia. BMC Pregnancy Childbirth 22(1):500. https:\/\/doi.org\/10.1186\/s12884-022-04827-4","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"6936_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/jcu.23077","volume":"50","author":"SCB Bremer","year":"2022","unstructured":"Bremer SCB, Richard F, Knoop RF, Porsche M, Amanzada A, Ellenrieder V, Neesse A, Kunsch S, Petzold G (2022) Pathological gallbladder wall thickening is associated with advanced chronic liver disease and independent of serum albumin. J Clin Ultrasound 50(3):367\u2013374. https:\/\/doi.org\/10.1002\/jcu.23077","journal-title":"J Clin Ultrasound"},{"key":"6936_CR12","doi-asserted-by":"crossref","unstructured":"Gadwood KA, Reynes CJ, Flisak ME, Gianopoulos J, Tomich P, Karlman R (1985) Gallbladder wall thickening in preeclampsia. JAMA 253(1):71\u201373. 10.1001","DOI":"10.1001\/jama.253.1.71"},{"key":"6936_CR13","doi-asserted-by":"publisher","unstructured":"Murata T, Yoshimoto Y, Shibano Y, Nakamura S, Yamauchi R (2021) Gallbladder wall thickening in a woman with postpartum preeclampsia: A case report. Case Rep Womens Health 33:e00370. https:\/\/doi.org\/10.1016\/j.crwh.2021.e00370","DOI":"10.1016\/j.crwh.2021.e00370"},{"key":"6936_CR14","doi-asserted-by":"publisher","unstructured":"Suarez B, Alves K, Senat MV, Fromageot J, Fischer C, Rosenberg P, Ville Y (2002) Abdominal pain and preeclampsia: sonographic findings in the maternal liver. J Ultrasound Med 21(10):1077-1083. https:\/\/doi.org\/10.7863\/jum.2002.21.10.1077","DOI":"10.7863\/jum.2002.21.10.1077"},{"key":"6936_CR15","unstructured":"V\u00e1zquez-Rodr\u00edguez JG, Chi\u00f1as-Vel\u00e1zquez S (2007) Caracter\u00edsticas ultrasonogr\u00e1ficas de la ves\u00edcula biliar en pacientes con preeclampsia-eclampsia [Ultrasonographic characteristics of biliary gallbladder in patients with preeclampsia-eclampsia]. Cir Cir 75(6):435\u2013442. Spanish. PMID: 18177564"},{"issue":"3","key":"6936_CR16","doi-asserted-by":"publisher","first-page":"395.e1","DOI":"10.1016\/j.ajog.2015.05.011","volume":"213","author":"Y Raz","year":"2015","unstructured":"Raz Y, Lavie A, Vered Y, Goldiner I, Skornick-Rapaport A, Landsberg Asher Y, Maslovitz S, Levin I, Lessing JB, Kuperminc MJ, Rimon E (2015) Severe intrahepatic cholestasis of pregnancy is a risk factor for preeclampsia in singleton and twin pregnancies. Am J Obstet Gynecol 213(3):395.e1\u20138. https:\/\/doi.org\/10.1016\/j.ajog.2015.05.011","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"6936_CR17","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00404-020-05456-y","volume":"301","author":"M Mor","year":"2020","unstructured":"Mor M, Shmueli A, Krispin E, Bardin R, Sneh-Arbib O, Braun M, Arbib N, Hadar E (2020) Intrahepatic cholestasis of pregnancy as a risk factor for preeclampsia. Arch Gynecol Obstet 301(3):655\u2013664. https:\/\/doi.org\/10.1007\/s00404-020-05456-y","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"6936_CR18","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1080\/10641955.2020.1758939","volume":"39","author":"A Arafaa","year":"2020","unstructured":"Arafaa A, Dong J-Y (2020) Association between intrahepatic cholestasis of pregnancy and risk of gestational diabetes and preeclampsia: a systematic review and meta-analysis. Hypertens Pregnancy 39(3):354\u2013360. https:\/\/doi.org\/10.1080\/10641955.2020.1758939","journal-title":"Hypertens Pregnancy"},{"key":"6936_CR19","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/hep.20336","volume":"40","author":"A Glantz","year":"2004","unstructured":"Glantz A, Marschall HU, Mattsson L\u00c5 (2004) Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 40:467\u2013474. https:\/\/doi.org\/10.1002\/hep.20336","journal-title":"Hepatology"},{"issue":"4","key":"6936_CR20","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1002\/hep.26444","volume":"58","author":"HU Marschall","year":"2013","unstructured":"Marschall HU, Shemer EW, Ludvigsson JF, Stephansson O (2013) Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease: a population-based cohort study. Hepatology 58(4):1385\u20131391. https:\/\/doi.org\/10.1002\/hep.26444","journal-title":"Hepatology"},{"issue":"11","key":"6936_CR21","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.placenta.2012.08.005","volume":"33","author":"EW Shemer","year":"2012","unstructured":"Shemer EW, Thorsell M, Ostlund E, Blomgren B, Marschall H-U (2012) Stereological assessment of placental morphology in intrahepatic cholestasis of pregnancy. Placenta 33(11):914\u2013918. https:\/\/doi.org\/10.1016\/j.placenta.2012.08.005","journal-title":"Placenta"},{"issue":"12","key":"6936_CR22","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.placenta.2011.09.006","volume":"32","author":"VL Geenes","year":"2011","unstructured":"Geenes VL, Lim Y-H, Bowman N, Tailor H, Dixon PH, Chambers J, Brown L, Wyatt-Ashmead J, Bhakoo K, Williamson C (2011) A placental phenotype for intrahepatic cholestasis of pregnancy. Placenta 32(12):1026\u20131032. https:\/\/doi.org\/10.1016\/j.placenta.2011.09.006","journal-title":"Placenta"},{"issue":"6","key":"6936_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4236\/jbm.2018.66003","volume":"6","author":"F Xie","year":"2018","unstructured":"Xie F, Liu X, Xiao P, Huang Y, Chen Q, Zhou L (2018) Bile acid effects on placental damage in intrahepatic cholestasis of pregnancy. J Biosci Med 6(6):42\u201352. https:\/\/doi.org\/10.4236\/jbm.2018.66003","journal-title":"J Biosci Med"},{"issue":"2","key":"6936_CR24","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jhep.2015.03.010","volume":"63","author":"EAW Shemer","year":"2015","unstructured":"Shemer EAW, Stephansson O, Thuresson M, Thorsell M, Ludvigsson JF, Marschall HU (2015) Intrahepatic cholestasis of pregnancy and cancer, immune-mediated and cardiovascular diseases: a population-based cohort study. J Hepatol 63(2):456\u2013461. https:\/\/doi.org\/10.1016\/j.jhep.2015.03.010","journal-title":"J Hepatol"},{"issue":"18","key":"6936_CR25","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.3109\/14767058.2014.983895","volume":"28","author":"EH Biberoglu","year":"2015","unstructured":"Biberoglu EH, Kirbas A, Kirbas O, Iskender C, Daglar HK, Koseoglu C, Uygur D, Danisman N (2015) Prediction of cardiovascular risk by electrocardiographic changes in women with intrahepatic cholestasis of pregnancy. J Matern Fetal Neonatal Med 28(18):2239\u20132243. https:\/\/doi.org\/10.3109\/14767058.2014.983895","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"4","key":"6936_CR26","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1002\/hep.26617","volume":"59","author":"V Geenes","year":"2014","unstructured":"Geenes V, Chappell LC, Seed PT, Steer PJ, Knight M, Williamson C (2014) Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study. Hepatology 59(4):1482\u20131491. https:\/\/doi.org\/10.1002\/hep.26617","journal-title":"Hepatology"},{"issue":"10174","key":"6936_CR27","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0140-6736(18)31877-4","volume":"393","author":"C Ovadia","year":"2019","unstructured":"Ovadia C, Seed PT, Sklavounos A, Geenes V, Di Illio C, Chambers J, Kohari K, Bacq Y, Bozkurt N et al (2019) Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet 393(10174):899\u2013909. https:\/\/doi.org\/10.1016\/S0140-6736(18)31877-4","journal-title":"Lancet"},{"key":"6936_CR28","doi-asserted-by":"publisher","unstructured":"Dong C, Condat B, Picon-Coste M, Chr\u00e9tien Y, Potier P, Noblinski B, Arriv\u00e9 L, Hauuy MP, Barbu V, Maftouh A, Gaouar F, Ben Belkacem K, Housset C, Poupon R, Zanditenas D, Chazouill\u00e8res O, Corpechot C (2020) Low-phospholipid-associated cholelithiasis syndrome: Prevalence, clinical features, and comorbidities. JHEP Rep 3(2):100201. https:\/\/doi.org\/10.1016\/j.jhepr.2020.100201","DOI":"10.1016\/j.jhepr.2020.100201"},{"issue":"3","key":"6936_CR29","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jhep.2020.04.036","volume":"73","author":"AF St\u00e4ttermayer","year":"2020","unstructured":"St\u00e4ttermayer AF, Halilbasic E, Wrba F, Ferenci P, Trauner M (2020) Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults. J Hepatology 73(3):651\u2013663. https:\/\/doi.org\/10.1016\/j.jhep.2020.04.036","journal-title":"J Hepatology"},{"key":"6936_CR30","doi-asserted-by":"publisher","unstructured":"Liu X, Jiusheng Zheng J, Xin S, Zeng Y, Wu X, Zeng X, Lai H, Zou Y (2022) Whole-exome sequencing expands the roles of novel mutations of organic anion transporting polypeptide, ATP-binding cassette transporter, and receptor genes in intrahepatic cholestasis of pregnancy. Front Genet 2022;13:941027. https:\/\/doi.org\/10.3389\/fgene.2022.941027","DOI":"10.3389\/fgene.2022.941027"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-023-06936-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-023-06936-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-023-06936-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T08:04:51Z","timestamp":1695629091000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-023-06936-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,28]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["6936"],"URL":"https:\/\/doi.org\/10.1007\/s00404-023-06936-7","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,28]]},"assertion":[{"value":"8 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no financial or non-financial interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is an observational study. Ethics committee approval is not required for such studies in the Ukraine.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}